Is CDKN2A p.Pro41Leu (c.122C>T) pathogenic?

CDKN2A p.Pro41Leu (c.122C>T) is classified Uncertain significance in CDKN2A (ClinVar, Single submitter, 1 submitter; last evaluated 2024-05-28). AlphaMissense: likely benign (0.2279); Very rare (popmax 0.000254%, nfe); Associated with hereditary neoplastic syndrome.

What condition is associated with CDKN2A p.Pro41Leu (c.122C>T)?

CDKN2A p.Pro41Leu (c.122C>T) is associated with hereditary neoplastic syndrome (ClinVar).

How common is CDKN2A p.Pro41Leu (c.122C>T) in the general population?

CDKN2A p.Pro41Leu (c.122C>T) is very rare (popmax 0.000254%, nfe) (gnomAD).

What do computational predictors say about CDKN2A p.Pro41Leu (c.122C>T)?

AlphaMissense predicts likely benign (score 0.2279) — an in-silico prediction, not a clinical call.

CDKN2A p.Pro41Leu

c.122C>T · rs373407950 · VCV1755177

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.2279 · ACMG-weighted

gnomAD v4.1

Rare

very rare (popmax 0.000254%, nfe)

Missense predictors

0/2 damaging

AlphaMissense, SaProt · REVEL no call

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense	0.2279	likely benign
REVEL	0.469	indeterminate
SaProt	LLR -3.34	tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -2.2	GERP -4.1
Regional constraint	o/e 1.13	unconstrained · MANE · 6,595 bp · p 0.04 · regional, not allelic
Overall
CADD	12.58	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.000254% European (non-Finnish) · 3/1,179,876 alleles

Filtering AF 6.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.9e-05%

Overall 0.000205% 3/1,460,848 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CDKN2A
Protein: p.Pro41Leu
Coding: c.122C>T
MANE Select: NM_000077
dbSNP: rs373407950
Type: single nucleotide variant
Location: chr9:21974706 (GRCh38)
Gene constraint: LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 77.02 · 5 PDB
Residue 41: an α-helix; the 'interaction with cdk5rap3 and mdm2' region

Full CDKN2A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

CDKN2A p.Ala41Thr Uncertain significance ★★ same residue
CDKN2A p.Pro41Ala Uncertain significance ★★ ⚠ same residue
CDKN2A p.Pro41Arg Uncertain significance ★★ ⚠ same residue
CDKN2A p.Pro41Ser Uncertain significance ★★ ⚠ same residue
CDKN2A p.Ala41= Likely benign ★★ same residue
CDKN2A p.Pro41Gln Conflicting classifications of pathogenicity ★ ⚠ same residue
CDKN2A p.Pro41fs Pathogenic ★★ same residue
CDKN2A p.Ala41fs Uncertain significance ★ same residue

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-pro41leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown